BHC BAUSCH HEALTH COMPANIES INC Company Mergers 8-K Filing 2023 - Acquisition of XIIDRA and ophthalmology assets from Novartis Bausch Health Companies Inc. filed a Current Report on Form 8-K providing financial information about the proposed acquisition of XIIDRA and other ophthalmology assets from Novartis.Get access to all SEC 8-K filings of the BAUSCH HEALTH COMPANIES INC